JAMA Oncology:化疗时不应该使用深海鱼油 或致化疗抵抗

2015-04-06 Zhang JL译 MedSci原创

OMEGA-3,又被写作 ω-3、Ω-3、w-3、n-3 ,为一组多元不饱和脂肪酸,常见于深海鱼类和某些植物中。在化学结构上, OMEGA-3 是一条由碳、氢原子相互连结而成的长链(18个碳原子以上),其间带有 3-6 个不饱和键(即双键)。因其第一个不饱和键位于甲基一端的第 3 个碳原子上,故名OMEGA-3。在过去的研究中,认为OMEGA-3具有以下作用:(1)促进中性或酸

lumi美国进口深海鱼油软胶囊 1000mg*60粒2瓶!
OMEGA-3,又被写作 ω-3、Ω-3、w-3、n-3 ,为一组多元不饱和脂肪酸,常见于深海鱼类和某些植物中。在化学结构上, OMEGA-3 是一条由碳、氢原子相互连结而成的长链(18个碳原子以上),其间带有 3-6 个不饱和键(即双键)。因其第一个不饱和键位于甲基一端的第 3 个碳原子上,故名OMEGA-3。在过去的研究中,认为OMEGA-3具有以下作用:(1)促进中性或酸性胆固醇自粪排出,抑制肝内脂质及脂蛋白合成,能降低血浆中胆固醇、甘油三酯、LDL、VLDL,增加HDL。(2)参与花生四烯酸(Eicosatetraeonic acid)代谢。生成前列腺素类化合物PGI3及TXA3。花生四烯酸的代谢物为前列环素(PGI2)和血栓素(TXA2);PGI2可舒张血管及抗血小板聚集、防止血栓形成;TXA2则可使血管痉挛、促进血小板聚集和血栓形成。PGI3的作用与PGI2相同;但TXA3却不具TXA2的作用。因此EPA和DHA具有舒张血管、抗血小板聚集和抗血栓作用。(3)抗心律失常、降低心率(4)降低血压。

近日,研究人员在小鼠体内研究中发现,食用鲱鱼和鲭鱼以及三种鱼油能够提高血液中16:4(n-3)脂肪酸水平的,而后者则是既往已经报道可能诱导机体对肿瘤化疗药物产生抵抗。该项研究结果发表在最新一期JAMA Oncology杂志上。

癌症患者经常对生活方式的进行调节和改变,而这些变化中往往包括补充品的使用,保健品就是其中之一。然而,这些保健品的使用到底对肿瘤以及肿瘤的治疗可能有怎样的影响,目前尚没有相关的文献报道。

来自阿姆斯特丹荷兰癌症研究所的Emile E. Voest博士及其合作者对人们食用鱼类或摄取鱼油后体内16:4(n-3)脂肪酸水平的变化进行了分析研究。

该研究团队以正在接受癌症治疗的患者以及健康志愿者为研究对象,通过血液检查检测,研究他们在进食鱼类以及摄于鱼油后血液中脂肪酸的水平。摄入鱼油组包括30名健康志愿者而进食鱼组包括20名健康志愿者。

研究结果显示,在接受回访的118名使用过营养保健品的癌症患者中,35例(占30%)报告称经常服用和13例(占11%)曾经服用含有ω-3脂肪酸的保健品。

研究发现,健康志愿者在被要求每日摄入10 mL鱼油后,其血液16:4(n-3)脂肪酸水平显著升高。在摄入这10 mL鱼油的8个小时后,其16:4(n-3)脂肪酸水平恢复至正常水平。而在服用50 mL鱼油后,血中16:4(n-3)脂肪酸水平需要恢复正常所需的时间明显延长。相比进食金枪鱼几乎没有影响血中16:4(n-3)脂肪酸水平,进吃100克的鲱鱼和鲭鱼增加了血液中16:4(n-3)脂肪酸水平,而进食鲑鱼则将导致16:4(n-3)脂肪酸水平出现一个短暂的峰值。

“我们的研究结果与越来越多的人所意识到的各种脂肪酸的生物活性及其受体与鱼油摄入以及化疗药物作用之间的复杂关系如出一辙。基于我们的研究结果,在获得进一步可用证据之前,我们建议病人从化疗的前一天到之后的第二天暂时避免服用鱼油。”该研究总结道。

原始出处:
Laura G. M. Daenen, Geert A. Cirkel, Julia M. Houthuijzen, Johan Gerrits, Ilse Oosterom, Jeanine M. L. Roodhart, Harm van Tinteren, Kenji Ishihara, Alwin D. R. Huitema, Nanda M. Verhoeven-Duif, Emile E. Voest. Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil. JAMA Oncology, 2015; DOI: 10.1001/jamaoncol.2015.0388

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-11-28 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-05-24 ljjj1053

    不错,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-04-23 yuena

    注意

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-04-15 吴颖

    那白萝卜呢!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-04-07 清氺訫

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2083730, encodeId=dff52083e3031, content=<a href='/topic/show?id=a23d6614ead' target=_blank style='color:#2F92EE;'>#深海鱼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66147, encryptionId=a23d6614ead, topicName=深海鱼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a6043, createdName=guoyibin, createdTime=Wed Nov 25 23:36:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864633, encodeId=9ab21864633c8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Nov 28 06:36:00 CST 2015, time=2015-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674360, encodeId=e70e16e4360d5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Thu May 28 15:36:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24722, encodeId=271824e225a, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sun May 24 12:49:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21756, encodeId=e29821e56af, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63461620684, createdName=yuena, createdTime=Thu Apr 23 11:27:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21200, encodeId=cd192120081, content=那白萝卜呢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Wed Apr 15 09:05:00 CST 2015, time=2015-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19665, encodeId=724f19665be, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19666, encodeId=cdcc19666d9, content=行, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/28/a28e8ea268716dfc601012321847bccf.jpg, createdBy=e21a1620364, createdName=清氺訫, createdTime=Tue Apr 07 00:15:00 CST 2015, time=2015-04-07, status=1, ipAttribution=)]
    2015-04-07 清氺訫

    0

相关资讯

癌症治疗令食物味道变得糟糕?

接受化疗的人们常说,化疗的最大副作用,即食物味道变得糟糕。意大利面味同嚼蜡,肉吃着有金属味。患者没有食欲,在对抗癌症和治疗的蹂躏时,也是他们最需要的时候,却最终只能得到很少的能量和营养。 为什么化疗会破坏食物的吸引力呢?是经常联合放疗使得事情变得更糟?美国科学家请求贝弗利科沃特(费城莫耐尔化学感官中心临床研究主任)解释其机制,以及可以让患者感觉食物更可口的策略。Photo courte

ChemMedChem:新型化疗方案能“定点”轰炸肿瘤细胞

在人类与肿瘤漫长的斗争史中,化疗占据着极其重要的位置。这种目前已经相当成熟的疗法自问世至今拯救了成千上万名肿瘤患者的生命。然而,由于传统化疗药物对机体地毯式的杀伤作用,往往会造成"杀敌一千,自损八百"的后果。这也导致相当一部分患者在接受化疗后出现了各种并发症,严重降低了患者的生存质量。因此,近几年无数科研人员都投身开发新型化疗疗法的研究中,希望能够找到一种合适的方法在保持对肿瘤杀伤的作用同时降低对

Clin Col Cancer:避免不必要药物副作用?血检也能做到!

一项由曼彻斯特研究人员发表的最新研究显示,血液测试能够在早期对肠癌患者是否获益于更为密集的化疗进行识别,进而为避免不必要的化疗而带来的药物副作用提供可能。该项研究结果发表在最新一期Clinical Colorectal Cancer杂志上。结直肠或肠道癌症是欧洲第二大癌症杀手。对于这一类肿瘤的治疗,最常见的方式是多种化疗药物联合应用,有助于提高药物治疗的效果。然而,这种多药联用的方法将可能增加药物

Ann Oncol:阿瑞匹坦or胃复安+地米预防顺铂致迟发性呕吐疗效相当

3月5日发表于《肿瘤学年鉴》(Ann Oncol)上的研究显示,两种方案预防顺铂导致的迟发性呕吐疗效相当,毒性相似。以顺铂为基础化疗的癌症患者中,接受相同的止吐剂预防急性呕吐后,在预防迟发性呕吐时阿瑞匹坦与地塞米松(A+D)并不优于胃复安与地塞米松(M+D)方案,两种方案的毒性相似。 5-HT3受体拮抗剂阿瑞匹坦(A)与地塞米松(D)联合方案推荐应用于预防顺铂引起的急性期或延迟性恶心呕吐

JCO:早期乳腺癌化疗或增加白血病患病风险

美国研究报道称,早期乳腺癌行预防性化疗或辅助化疗后,罹患白血病的风险将增加,这也意味着额外的治疗并不一定能带来额外的生存获益。他们发现行辅助化疗或预防性化疗的早期乳腺癌患者 10 年罹患白血病累积风险为 0.5%,大约为之前研究报告的 2 倍。该报告的研究者是来自约翰霍普金斯大学医学院肿瘤学的荣誉教授 Judith Karp 博士,他在一份通讯稿中说,骨髓肿瘤如白血病的发病率低,这是毫无疑问的